Dafna Bar-Sagi, PhD, was named Senior Vice President and Vice Dean for Science, Chief Scientific Officer of NYU Langone Health in summer 2011, and Executive Vice President in 2019. She is also a Professor of Biochemistry and Molecular Pharmacology.
One of the country’s leading cancer biologists, Dr. Bar-Sagi is widely known for elucidating cellular pathways involved in controlling cell growth. She has published more than 150 peer-reviewed research papers in leading journals on the molecular mechanisms underlying tumor development, devoting considerable research to RAS proteins, essential control elements of molecular machineries that drive the neoplastic process in many human cancers.
Prior to joining the Medical Center in 2006 as chair of the Department of Biochemistry, Dr. Bar-Sagi headed the Department of Molecular Genetics and Microbiology at the State University of New York (SUNY) at Stony Brook. She earned her undergraduate and master’s degrees from Bar-Ilan University, Israel, and her PhD from SUNY at Stony Brook. She has been a member of many scientific advisory boards, including the National Cancer Institute, Starr Cancer Consortium, Pancreatic Cancer Action Network, and Abramson Family Cancer Research Institute, and has served on the editorial boards of multiple journals, including Cancer Cell, Oncogene, and Molecular and Cellular Biology.